copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Prostate cancer Information | Mount Sinai - New York The Gleason Grading System The Gleason grading system refers to how abnormal your prostate cancer cells look and how likely the cancer is to advance and spread A lower Gleason grade means that the cancer is slower growing and not as aggressive Gleason Score The first step in determining the Gleason grade is to determine the Gleason score
Prostate cancer staging Information | Mount Sinai - New York The higher the stage, the more advanced the cancer Stage I cancer The cancer is found only in one part of the prostate Stage I is called localized prostate cancer It cannot be felt during a digital rectal exam or seen with imaging tests If the PSA is less than 10 and the Gleason score is 6 or less, Stage I cancer is likely to grow slowly Stage II cancer The cancer is more advanced than
CRTV-7615_MSHS_Menon Precision Prostatectomy_Brochure. indd If you have cancer that is clinically insignifi cant (Gleason 6), we would recommend active surveillance However, if there is clinically signifi cant cancer (any Gleason 7, more than 2 cores of Gleason 6 or any core more than 3 mm), we recommend additional treatment This could involve removal of the residual tissues, radiation or tissue ablation
Active Surveillance | Mount Sinai - New York Active surveillance is most appropriate for you medically if: You aren’t experiencing any symptoms You have a slow-growing cancer (Gleason score of less than 6) Your cancer is small (cannot be seen on a digital rectal exam or ultrasound) The cancer is only in the prostate (localized) You have a low PSA level (less than 10 mg ml)
Treatments | Mount Sinai - New York We use the Gleason Score grading system to determine appropriate treatment options based on how aggressive your cancer is The higher the score, the more quickly the cancer will grow Determining whether and how to treat prostate cancer is a personal decision Some people prefer active surveillance, if appropriate
Pathology Test Uses Artificial Intelligence to Predict Prostate Cancer . . . A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following surgery, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published in Nature Prostate Cancer and Prostatic Diseases The Precise MD post-op test automates the Gleason score (a